IceCure Medical Ltd. Research and Development Expense
IceCure Medical Ltd. (ICCM) reported Research and Development Expense of $7.43 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-03-17
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $7.43M 20-F · filed 2026-03-17 | |
| 2025-06-30 | $3.38M 6-K · filed 2025-08-13 | |
| 2024-12-31 | $7.10M 20-F · filed 2026-03-17 | |
| 2024-06-30 | $3.54M 6-K · filed 2025-08-13 | |
| 2023-12-31 | $8.27M 20-F · filed 2026-03-17 | |
| 2023-06-30 | $4.19M 6-K · filed 2024-08-20 | |
| 2022-12-31 | $9.12M 20-F · filed 2025-03-27 | |
| 2022-06-30 | $4.65M 6-K · filed 2023-08-14 | |
| 2021-12-31 | $5.88M 20-F · filed 2024-04-03 | |
| 2021-06-30 | $2.73M 6-K · filed 2022-09-22 | |
| 2020-12-31 | $3.81M 20-F · filed 2023-03-29 | |
| 2019-12-31 | $3.00M 20-F/A · filed 2022-08-22 |